Role Of Sglt2 Inhinitors in Modern Medicine
Clinical Sciences and Clinical Research · 2023
DOI: 10.58489/2836-8959/003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Sciences and Clinical Research, 2023. Verfasst von Jayesh Trivedi.
Abstract (Originalsprache)
SGLT2 inhibitor is a new invention in medical practice which has changed the progress and treatment part of life threatning medical conditions like type 2 diabetes mellitus causing chronic kidney disease and end stage renal disease, it has changed the concept of treatment of cardicac failure also with compromised left ventricular ejection fraction and retained left ventricular ejection fraction, in combination of dpp4 inhibitor and metformin as a part of polypill it has shown great results with compliance and economy in control of diabetes mellitus, it does not give rise to exhaustion of islets of beta cells of langerhans as it does not affect the endocrinal function of the pancreas and this combination controls hba1c drastically(1.2)without causing hypoglycemia, thus it becomes a treatment of choice in triple drug therapy as an alternative to glp1 receptor agonist ,it can be given in dual therapy treatment, so in cases of diabetes mellitus type 2 with lv dysfunction this becomes a treatment of choice
Zitieren
APA
Trivedi, J. (2023). Role Of Sglt2 Inhinitors in Modern Medicine. Clinical Sciences and Clinical Research. https://doi.org/10.58489/2836-8959/003
Vancouver
Trivedi J. Role Of Sglt2 Inhinitors in Modern Medicine. Clinical Sciences and Clinical Research. 2023. doi:10.58489/2836-8959/003
BibTeX
@article{Trivedi2023,
author = {Trivedi, Jayesh},
title = {Role Of Sglt2 Inhinitors in Modern Medicine},
journal = {Clinical Sciences and Clinical Research},
year = {2023},
doi = {10.58489/2836-8959/003}
}
EUVIMED